JENNA GADDY: Open Payments
NPI 1114470143 · CRYSTAL SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 33 payments from 9 companies in 2025. Trend: 2023 $217 · 2024 $614 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $315 |
| Lilly USA, LLC | 4 | $94 |
| ABBVIE INC. | 3 | $62 |
| PFIZER INC. | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Exact Sciences Corporation | 1 | $16 |
| Amgen Inc. | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, MOUNJARO, JARDIANCE, QULIPTA, FARXIGA, SHINGRIX, PREVNAR 20.
Industry payments across MS — which companies pay providers there.
